Persium Advisors’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$921K Buy
11,767
+2,401
+26% +$194K 0.6% 34
2026
Q1
$812K Buy
9,366
+538
+6% +$51.5K 0.64% 28
2025
Q4
$848K Buy
8,828
+395
+5% +$38.4K 0.61% 23
2025
Q3
$803K Buy
8,433
+487
+6% +$44.8K 0.6% 25
2025
Q2
$693K Buy
7,946
+343
+5% +$29.1K 0.57% 26
2025
Q1
$683K Buy
7,603
+337
+5% +$30.2K 0.65% 18
2024
Q4
$580K Buy
+7,266
New +$629K 0.57% 30

Other funds holding MDT

Persium Advisors's MDT Position: Q2 2026 in Review

Persium Advisors increased its Medtronic (MDT) stake by 26% in Q2 2026, buying an estimated $194K and bringing the position to 11,767 shares worth $921K. The position accounts for 0.6% of the portfolio, ranked #34.

Persium Advisors first reported a position in MDT in Q4 2024 and has held it in 7 quarters since. 2,134 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Persium Advisors held 11,767 shares of Medtronic worth $921K as of Q2 2026.
  • Persium Advisors bought 2,401 Medtronic shares in Q2 2026, an estimated $194K.
  • Medtronic made up 0.6% of Persium Advisors's portfolio in Q2 2026, its #34 holding.
  • Persium Advisors first reported a position in Medtronic in Q4 2024 and has held it in 7 quarters since.
  • 2,134 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Persium Advisors's 13F filing for Q2 2026, filed 3 Aug 2026.